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Abstract
Background: The presence and extent of microvascular obstruction (MO) after acute myocardial infarction can be measured
by first-pass gadolinium-enhanced perfusion cardiovascular magnetic resonance (CMR) or after gadolinium injection with early
or late enhancement (EGE/LGE) imaging. The volume of MO measured by these three methods may differ because contrast
agent diffusion into the MO reduces its apparent extent over time. Theoretically, first-pass perfusion CMR should be the most
accurate method to measure MO, but this technique has been limited by lower spatial resolution than EGE and LGE as well as
incomplete cardiac coverage. These limitations of perfusion CMR can be overcome using spatio-temporal undersampling
methods. The purpose of this study was to compare the extent of MO by high resolution first-pass k-t SENSE accelerated
perfusion, EGE and LGE.
Methods: 34 patients with acute ST elevation myocardial infarction, treated successfully with primary percutaneous coronary
intervention (PPCI), underwent CMR within 72 hours of admission. k-t SENSE accelerated first-pass perfusion MR (7 fold
acceleration, spatial resolution 1.5 mm × 1.5 mm × 10 mm, 8 slices acquired over 2 RR intervals, 0.1 mmol/kg Gd-DTPA), EGE
(14 minutes after injection with a fixed TI of 440 ms) and LGE images (1012 minutes after injection, TI determined by a Look-
Locker scout) were acquired. MO volume was determined for each technique by manual planimetry and summation of discs
methodology.
Results: k-t SENSE first-pass perfusion detected more cases of MO than EGE and LGE (22 vs. 20 vs. 14, respectively). The extent
of MO imaged by first-pass perfusion (median mass 4.7 g, IQR 6.7) was greater than by EGE (median mass 2.3 g, IQR 7.1, p =
0.002) and LGE (median mass 0.2 g, IQR 2.4, p = 0.0003). The correlation coefficient between MO mass measured by first-pass
perfusion and EGE was 0.91 (p < 0.001).
Conclusion: The extent of MO following acute myocardial infarction appears larger on high-resolution first-pass perfusion
CMR than on EGE and LGE. Given the inevitable time delay between gadolinium administration and acquisition of either EGE
or LGE images, high resolution first-pass perfusion imaging may be the most accurate method to quantify MO.
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Introduction
The basic aim of reperfusion therapy in acute myocardial
infarction (AMI) is to restore normal blood flow to the
ischemic myocardium as quickly as possible. Recanalisa-
tion of the infarct-related artery by primary percutaneous
coronary intervention (PPCI), in particular, has seen sig-
nificant reductions in mortality after AMI by limiting the
amount of myocardial necrosis [1,2]. However, restora-
tion of patency in the epicardial coronary artery some-
times fails to translate into recovery of myocardial
function and in up to 30% of patients, reperfusion of the
ischemic territory is incomplete due to myocardial micro-
vascular obstruction (MO), which is seen angiographi-
cally as "no-reflow" [3]. Recent studies have demonstrated
that MO plays a significant role in the pathophysiology of
myocardial infarction and affects prognosis through an
association with complications and poor recovery of left
ventricular function [4-9].
Although there are several quantitative measures of angi-
ographic perfusion such as corrected TIMI frame count
[10], TIMI myocardial perfusion grade [11] and blush
score [12], none of these directly visualise the affected
myocardium. Gadolinium-enhanced CMR has emerged
as an accurate tool to measure ventricular function, extent
of infarction and MO [13,14]. The most common CMR
technique to identify MO uses inversion recovery acquisi-
tion following intravenous administration of a gadolin-
ium-based contrast agent. The preferred delay between
gadolinium administration and image acquisition is 13
minutes ("early gadolinium enhancement", EGE),
although many studies have measured MO from images
acquired more than ten minutes after gadolinium admin-
istration ("late gadolinium enhancement", LGE). How-
ever, gadolinium chelates are freely permeable through
the vascular wall and, therefore, will passively diffuse
from normally perfused myocardium into the areas of
microvascular damage over time. Hence, delayed imaging
may underestimate the extent of MO.
Alternatively, MO can be identified by gadolinium
enhanced first-pass myocardial perfusion CMR. In princi-
ple, first-pass perfusion would be expected to be the most
accurate measure of MO size because it allows less time
than either EGE or LGE for diffusion of gadolinium to
artifactually diminish MO volume. Comparative studies
of first-pass perfusion with LGE have confirmed this,
showing larger MO extent by first-pass perfusion than
LGE [15,16]. However, conventionally first-pass per-
fusion affords only about half the spatial resolution of
EGE and LGE and typically does not cover the entire heart.
In this study, we sought to compare k-t SENSE accelerated
first-pass perfusion with high spatial resolution and
extended cardiac coverage with both EGE and LGE in the
assessment of MO after acute myocardial infarction. We
hypothesized that the appearance of MO on first-pass per-
fusion, acquired with the same spatial resolution as EGE
and LGE and with comparable ventricular coverage,
would be larger than with the other two methods.
Methods
We recruited 34 consecutive patients hospitalised with
first presentation acute ST elevation myocardial infarction
and treated successfully with PPCI within 12 hours of
symptom onset. Patients were recruited from two cardiac
centres in the United Kingdom, Leeds General Infirmary
and St. Thomas' Hospital, London. The study was
approved by the institutional Research Ethics Committee
and complied with the Declaration of Helsinki; written
informed consent was obtained from all patients. Patients
with a history of previous coronary revascularisation (i.e.
PCI or coronary artery bypass surgery), previous myocar-
dial infarction, renal failure or contraindication to CMR
examination, were excluded.
CMR protocol
All CMR studies were performed on Philips Achieva 1.5
Tesla MR systems (Philips Healthcare, Best, The Nether-
lands), using the same scanning protocol. All patients
underwent CMR within 72 hours of reperfusion therapy.
Cine images of the entire left ventricle were acquired using
an ECG-gated balanced steady state free precession (SSFP)
pulse sequence. Following this, an intravenous bolus dose
of 0.1 mmol/kg Gd-DTPA (Dimeglumine gadopentetate,
Magnevist, Bayer Schering Health Care Limited, UK) was
administered at a rate of 5 ml/s by a power injector
(Medrad Spectris Solaris, Medrad, USA). k-t SENSE accel-
erated first-pass perfusion imaging was performed simul-
taneously with the injection of gadolinium, using the
following imaging parameters: Fast gradient echo, repeti-
tion time (TR) 3.7 ms, echo time (TE) 1.0 ms, flip angle
15°, 7-fold k-t acceleration, 11 training profiles, spatial
resolution 1.5 mm × 1.5 mm × 10 mm, field of view
(FOV) range 350400 mm, 8 slices acquired in the left ven-
tricular (LV) short axis over 2 RR intervals and no
interslice gap.
Immediately after first-pass perfusion imaging, a second
bolus dose of 0.1 mmol/kg Gd-DTPA was administered.
EGE images were acquired 14 minutes after gadolinium
injection with a fixed inversion time (TI) of 440 ms (inver-
sion recovery-prepared T1-weighted gradient echo, TR 4.9
ms, TE 1.9 ms, flip angle 15°, spatial resolution 1.35 mm
× 1.35 mm × 10 mm, FOV range 350400 mm, 10 two-
dimensional slices in LV short axis and no interslice gap).
In our practice we routinely use a fixed TI of 440 ms as it
provides excellent contrast between microvascular
obstruction and normal myocardium. Normal myocar-Journal of Cardiovascular Magnetic Resonance 2009, 11:33 http://www.jcmr-online.com/content/11/1/33
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dium appears bright compared with the low signal inten-
sity of MO.
10 minutes after gadolinium injection, a 'Look Locker'
sequence was performed to obtain the most appropriate
TI to null the signal intensity of normal myocardium. The
minimum TI for the study group was 225 ms and the max-
imum was 250 ms. The median TI was 240 ms. LGE
images were then acquired 1015 minutes after gadolin-
ium injection with identical pulse sequence parameters as
for EGE apart from the specifically determined TI.
CMR analysis
The CMR images were analysed off-line using commercial
software (MASS 6.0, Medis, Leiden, The Netherlands) by
an observer blinded to all other data and all clinical
details. For assessment of left ventricular function and
mass, the end-diastolic and end-systolic cine frames were
identified for each slice and the endocardial and epicar-
dial borders were manually traced. The end-diastolic and
end-systolic volumes were then calculated using Simp-
son's rule (i.e. sum of cavity sizes across all continuous
slices).
For first-pass perfusion data, the frame demonstrating
peak signal intensity in the remote normal myocardium
was chosen for quantitation of the myocardial extent of
the perfusion defect. The perfusion defect was defined vis-
ually as a hypoenhanced region and then planimetered
manually. A total volume of MO was then calculated by
Simpson's rule. The presence of dark rim artifacts is much
reduced with high resolution first-pass perfusion
sequences [17]. Where artifacts were present and occurred
in the territory of the infarct, contours were drawn to
exclude the artifacts. Papillary muscle was excluded from
all analyses. Image quality of the first-pass perfusion
images was assessed by consensus opinion (ANM and AS)
and scored on a scale of 1 to 4, as follows: (1) unable to
interpret results, (2) poor, (3) satisfactory and (4) very
good.
EGE images were assessed in a similar manner. For each
slice, the region of hypoenhancement, compared to nor-
mal myocardium, was defined visually and then planime-
tered manually. LGE images were assessed both for infarct
size and MO. The endocardial and epicardial borders on
each slice were traced manually. Infarcted tissue was
defined as areas with late gadolinium enhancement.
These regions were identified and then quantified using a
semi-automated algorithm. Areas of enhancement were
defined as myocardium with a signal intensity > 2 SD
above the mean signal intensity of the remote normal
myocardium [18]. The mass of infarcted myocardium was
then automatically calculated. MO on LGE imaging was
defined as a region of subendocardial hypoenhancement
within the enhanced region (Figure 1). The area of MO
was manually planimetered and a volume was calculated
using Simpson's rule. All volumes were converted to mass
by multiplying by the myocardial density (1.05 g/ml). For
each method of assessment of MO, the transmural and
circumferential extent of MO was measured in the slice
that demonstrated the maximum area of MO.
In all patients, data acquisition was commenced at the
same time points after gadolinium administration (i.e. at
1 minute for EGE and at 10 minutes for LGE). However,
because EGE and LGE data are 2D stacks acquired over
several breath holds, the acquisition duration of each
stack varies with patients' breath-holding capacity and
heart rate. Because the signal characteristics change over
time in both EGE and LGE, we investigated whether the
duration of the data acquisition could be a confounding
variable for the results. We sought to determine if the
greatest differences between first-pass perfusion and EGE
and LGE measurements of MO were attributable to the
cases which had the greatest image acquisition durations.
Statistical analysis
Statistical analysis was performed using commercially
available software (SPSS, version 15.0, SPSS Inc, Chicago,
USA). Two-sided p values ≤ 0.05 were considered to be
statistically significant. Data were compared using Stu-
dent's paired t tests, independent samples t tests and Pear-
son's correlation coefficients. Continuous data are
represented as median values and interquartile ranges
(IQR). The agreements between the methods first-pass
perfusion, EGE and LGE were demonstrated using Bland-
Altman plots.
The reproducibility of MO assessment for each technique
was assessed using a random sample of ten patients. In
order to assess intra-observer variability, MO contours
were redrawn several months after the original contours,
and without reference to them, by the original observer
(ANM). An additional observer (AS) independently drew
contours using the same images in order to assess inter-
observer variability. It was firstly confirmed that the
degree of error between repeated measurements was not
proportional to the magnitude of the measurements,
using Kendall's correlation coefficient and scatter plots.
The variance between repeated measurements of MO by
first-pass perfusion, EGE and LGE was then calculated for
each patient. The within-subject variance for each tech-
nique was obtained by taking the mean of the ten patients'
variances. The within-subject standard deviation was then
derived by performing the square root of the within-sub-
ject variance.
The intra-observer and inter-observer variabilities were
also assessed by calculating the Coefficient of VariationJournal of Cardiovascular Magnetic Resonance 2009, 11:33 http://www.jcmr-online.com/content/11/1/33
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A) CMR images from a patient with acute lateral myocardial infarction Figure 1
A) CMR images from a patient with acute lateral myocardial infarction. Arrows point to MO (areas of hypoen-
hancement) on first-pass perfusion (left), EGE (middle) and LGE (right). B) CMR images from a patient with acute anterior 
myocardial infarction. Arrows point to MO (areas of hypoenhancement) on first-pass perfusion (left), EGE (middle) and LGE 
(right).
Table 1: Summary of baseline characteristics of study patients (n = 34)
N = 34
Age (median, interquartile range) 63 (IQR 5666)
Male % 2
Current smoking % 50
Family history of premature coronary artery disease % 29
Hypertension % 29
Hypercholesterolaemia % 35
Diabetes % 9
Infarct-related artery %
Left anterior descending artery 32
Left circumflex artery 24
Right coronary artery 44
Primary percutaneous coronary intervention (PPCI) % 100
TIMI flow post-PCI %
TIMI 3 85
TIMI 2 15
TIMI1 0
Use of Glycoprotein 2b/3a inhibitors % 53
Use of Bivalirudin % 47
Use of percutaneous thrombectomy device % 21Journal of Cardiovascular Magnetic Resonance 2009, 11:33 http://www.jcmr-online.com/content/11/1/33
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(CV) or error within a single measurement estimated from
repeated measurements. By using the formula: Sw = Sd/v2,
where Sw is the common within subject standard devia-
tion and Sd is the standard deviation of the differences
between two measurements, CV was then calculated using
the formula: CV = (Sw/x) × 100, where x is the total mean
of all measurements.
Results
The baseline characteristics of the study population are
summarised in Table 1. The median image quality score
for the first-pass perfusion images was 3 (i.e. satisfactory).
Only four cases were deemed to be of poor quality and all
images were interpretable. The intra-observer variability
and inter-observer variability assessments for the meas-
urement of MO by the three different techniques are out-
lined in Table 2. Evidence of myocardial infarction by LGE
was present in all cases. The median infarct mass was 21.9
g (IQR 11.4). The median left ventricular ejection fraction
(LVEF) was 41.6% (IQR 7.7).
k-t SENSE first-pass perfusion detected more cases of MO
than EGE and LGE (22 vs. 20 vs. 14, respectively). There
were no cases where MO was detected by EGE or LGE and
not by first-pass perfusion. The LV mass was consistent
when measured by the three different imaging techniques.
Therefore, the extent of MO is represented by the absolute
measurement in grams. The extent of MO imaged by first-
pass perfusion (median mass 4.7 g, IQR 6.7) was signifi-
cantly greater than EGE (median mass 2.3 g, IQR 7.1, p =
0.002) and LGE (median mass 0.2 g, IQR 2.4, p = 0.0003).
The extent of MO measured by EGE was greater than by
LGE (p = 0.004). There was a positive correlation between
MO mass measured by first-pass perfusion and EGE (r =
0.91, p < 0.001) (Figure 2) and between first-pass per-
fusion and LGE (r = 0.55, p = 0.002). The bias and limits
of agreement between these methods of assessing MO are
demonstrated in the Bland-Altman plots in Figure 3, Fig-
ure 4 and Figure 5.
The transmural extent of MO was greater in every case by
first-pass perfusion, except in two patients where the
greatest extent was measured by EGE. The circumferential
extent of MO was largest by first-pass perfusion in all
cases.
The minimum time to the first CMR scan was 28 hours
and the maximum time was 72 hours (median 52 hours,
IQR 26.25). There were no significant correlations
between the time to first CMR scan and the MO/infarct
size ratio measured by the three different CMR techniques
(first-pass perfusion r = 0.37, p = 0.09; EGE r = 0.15, p =
0.52; LGE r = 0.26, p = 0.24).
We tested whether the image acquisition durations for
EGE and LGE were related to the differences in the extent
of MO measured by these techniques. The difference
between MO mass as measured by first-pass perfusion and
EGE did not correlate with the acquisition duration for
EGE (r = 0.014, p = 0.95). Similarly, the difference
between MO mass as measured by first-pass perfusion and
LGE did not correlate with the acquisition duration for
LGE (r = -0.39, p = 0.07). There was also no evidence of an
exponential or logarithmic correlation.
In this study, 18 (53%) patients received a Glycoprotein
(GP) IIb/IIIa inhibitor and 16 (47%) patients received
Bivalirudin (direct thrombin inhibitor) as adjunctive
pharmacotherapy during the PPCI procedure. There were
no significant differences between these two treatment
groups regarding the mass of MO measured by first-pass
perfusion (median MO mass (g) (IQR), GP IIb/IIIa 5.63
(9.3) vs. Bivalirudin 2.42 (6.67), p = 0.12); EGE (GP IIb/
IIIa 6.2 (10.2) vs. Bivalirudin 2.70 (6.82), p = 0.07 or LGE
(GP IIb/IIIa 2.41 (2.38) vs. Bivalirudin 1.58 (3.43), p =
0.55).
Discussion
This study shows that in patients with recent AMI, success-
fully treated with PPCI, high-resolution first-pass per-
fusion CMR identifies more cases of MO than EGE and
LGE and that the extent of MO appears larger on first-pass
perfusion than either EGE or LGE.
Angiographic assessments of MO such as corrected TIMI
frame count and myocardial blush grade are well vali-
dated [19] but lack sensitivity and specificity. In addition,
Table 2: Summary of the intra-observer variability and inter-observer variability assessments for the measurement of MO by first-pass 
perfusion, EGE and LGE.
Method of MO 
assessment
Intra-observer variability Inter-observer variability
Within-subject SD (g) Coefficient of variation 
(%)
Within-subject SD (g) Coefficient of variation 
(%)
First-pass perfusion 0.65 5.2 0.54 6.54
EGE 0.48 8.14 0.29 4.89
LGE 0.2 6.29 0.32 10.16Journal of Cardiovascular Magnetic Resonance 2009, 11:33 http://www.jcmr-online.com/content/11/1/33
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Graph demonstrating correlation between MO mass (g)  measured by k-t SENSE first-pass perfusion and EGE (r =  0.91) Figure 2
Graph demonstrating correlation between MO mass 
(g) measured by k-t SENSE first-pass perfusion and 
EGE (r = 0.91). Diagonal black line represents the line of 
identity.
Bland-Altman plot demonstrating the agreement of MO mass  as measured by first-pass perfusion and EGE Figure 3
Bland-Altman plot demonstrating the agreement of 
MO mass as measured by first-pass perfusion and 
EGE. The central horizontal line represents the mean bias 
and the red dashed lines represent the limits of agreement 
(i.e. 2 SD from the mean difference of MO mass measured by 
first-pass perfusion minus EGE).
Bland-Altman plot demonstrating the agreement of MO mass  as measured by first-pass perfusion and LGE Figure 4
Bland-Altman plot demonstrating the agreement of 
MO mass as measured by first-pass perfusion and 
LGE. The central horizontal line represents the mean bias 
and the red dashed lines represent the limits of agreement 
(i.e. 2 SD from the mean difference of MO mass measured by 
first-pass perfusion minus LGE).
Bland-Altman plot demonstrating the agreement of MO mass  as measured by EGE and LGE Figure 5
Bland-Altman plot demonstrating the agreement of 
MO mass as measured by EGE and LGE. The central 
horizontal line represents the mean bias and the red dashed 
lines represent the limits of agreement (i.e. 2 SD from the 
mean difference of MO measured by EGE minus LGE).Journal of Cardiovascular Magnetic Resonance 2009, 11:33 http://www.jcmr-online.com/content/11/1/33
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such methods do not allow direct visualisation of the
affected myocardium and the extent of MO may continue
to evolve over the hours and days following AMI meaning
an assessment made immediately after reperfusion may
lack accuracy [20]. The exposure of patients to ionising
radiation and risk of procedural complications means that
these methods are not suitable for serial monitoring
which is needed to further our understanding of the
pathophysiology as well as evaluate new treatments. In
this regard, a non-invasive and safe imaging modality,
such as CMR, is ideal.
CMR is the gold standard assessment of left ventricular
mass and function [21] and has the best interstudy repro-
ducibility of any technique for these assessments [22].
Gadolinium-enhanced CMR has also been used exten-
sively in the study of myocardial infarction and MO
[13,14,23,24]. Researchers have used different methods
for detecting MO. Some studies have highlighted the
prognostic significance of MO, defined by EGE or LGE, in
predicting left ventricular remodeling, adverse cardiovas-
cular complications and persistent functional impairment
[6,25-27]. First-pass perfusion imaging has been used by
others to demonstrate MO as a predictor of poor func-
tional recovery after myocardial infarction [28,29].
There are two comparisons in the published literature
between first-pass perfusion and LGE in the detection of
MO. Both found that first-pass perfusion detected MO
more frequently and to a greater extent [15,16]. Our
research confirms these findings. However, both of these
studies used LGE as the delayed enhancement technique
rather than EGE. A further limitation of both studies was
the incomplete left ventricular coverage by first-pass per-
fusion. Lund et al., used single slice perfusion and Yan et
al., used 3 slices. Therefore, localised microvascular dys-
function was likely to be missed and this possibly
accounted for small numbers of patients in both studies
with evidence of MO by LGE but not first-pass perfusion.
In the present study, we compared high resolution accel-
erated k-t SENSE first-pass perfusion with both EGE and
LGE methods. The accelerated perfusion sequence
allowed almost full ventricular coverage in a single breath-
hold by acquiring data over 2 RR intervals and the
acquired spatial resolution was comparable to EGE and
LGE, therefore overcoming the limitations of previous
studies of first-pass perfusion. We suggest that high spatial
resolution and good ventricular coverage were the reasons
why we found more patients with MO on first-pass per-
fusion than EGE or LGE and demonstrated a significant
difference in the extent of MO. In doing so, our observa-
tions support previous suggestions that gadolinium pas-
sively diffuses into areas of microvascular damage
immediately following gadolinium injection and, there-
fore, the apparent size of MO may decrease over a rela-
tively short time period after injection of a gadolinium-
based contrast agent.
In the absence of a reference standard for in vivo assess-
ment of MO, the differences we have observed in the
apparent MO dimensions with different CMR methods
may in part reflect technical differences between the three
CMR methods. In addition, several physiological phe-
nomena may affect the three CMR methods differently.
On first-pass perfusion for example, old myocardial inf-
arction may produce hypoenhancement, while it would
lead to enhancement on EGE and LGE. In our sample, this
is unlikely to have been a confounding factor as none of
the study subjects had suffered previous MI. Rarely, at rest,
first-pass perfusion can produce an area of hypoenhance-
ment in a myocardial territory dependent on a tight coro-
nary artery stenosis. In this study, however, there were no
cases with perfusion defects in more than one coronary
artery territory and in all cases the perfusion defects
matched the territory of the infarct related artery. Finally,
areas of an acute myocardial infarction may be dependent
on collateral flow. It is possible that collateral flow
dependent myocardium will demonstrate late gadolin-
ium enhancement relative to the remote normal myocar-
dium and that this could therefore, contribute to the
greater extent of MO measured by first pass perfusion.
Rochitte et al.[20], demonstrated in dogs that the MO/inf-
arct size ratio is not stable and increases over the first 48
hours after AMI. In order to minimize the potential influ-
ence of this phenomenon on comparisons made in our
study, we aimed to perform CMR between 48 and 72
hours after presentation with AMI. Our results demon-
strated that there were no significant correlations between
MO/infarct size ratio and time to CMR scan for all three
CMR techniques.
In this study, 29 (85%) patients had TIMI 3 flow and 5
(15%) patients had TIMI 2 flow following primary PCI.
These findings are consistent with other studies, e.g.
Nijveldt et al. (2008) [27] examined 60 patients with AMI
treated successfully with PPCI, and found TIMI 3 flow in
82% and TIMI 2 flow in 18% of cases. They detected MO
in 68% of cases. Therefore, microvascular dysfunction is
not solely dependent on restoration of epicardial coro-
nary artery patency. Ischemia itself causes ultrastructural
damage to the microvasculature and electron microscopy
has revealed endothelial abnormalities, neutrophil occlu-
sion and marked erythrocyte stasis at the level of capillar-
ies [3]. Indeed, successful reperfusion itself can lead to
additional injury to the microvasculature by causing fur-
ther neutrophil infiltration, free radical generation and
activation of the complement system [9]. In addition,
compression of the microvasculature by edematous andJournal of Cardiovascular Magnetic Resonance 2009, 11:33 http://www.jcmr-online.com/content/11/1/33
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necrotic myocytes can increase distal vascular resistance
and cause arteriolar spasm. Platelet microembolization
following coronary artery plaque rupture and then PCI
may also play a significant role [9].
Although there were no statistically significant differences
between patients treated with GP IIb/IIIa inhibitors and
Bivalirudin, the former treatment was associated with a
trend to larger MO as assessed by all three CMR methods.
These initial observations may warrant evaluation in
larger future studies.
Limitations
The present study did not compare the CMR methods of
assessment of MO with a validated reference standard.
However, this has been studied before with demonstra-
tion of good correlation between CMR and TIMI frame
count [16]. Also, we did not match our findings to clinical
outcome measures, although MO measured by first-pass
perfusion and delayed enhancement CMR has been
shown to correlate with infarct mass and left ventricular
ejection fraction [16], which are both established prog-
nostic markers following AMI.
Conclusion
In conclusion, we demonstrated that high resolution first-
pass perfusion CMR detected MO more frequently and to
a greater extent than either early or late gadolinium
enhancement CMR methods. We postulate that first-pass
perfusion imaging is likely to give the most accurate
assessment of MO, as it is not confounded by the diffu-
sion of gadolinium into the no-reflow zone over time,
which will lead to an underestimation of MO by any
delayed acquisition, regardless of timing. By using k-t
SENSE acceleration and acquisition over 2 RR intervals we
were able to assess MO with the same spatial resolution
and cardiac coverage as current EGE and LGE techniques,
making first-pass perfusion a viable and more time-effi-
cient alternative to these methods. Given that outcome
after AMI is related to the presence and extent of MO,
future studies are warranted to determine if the detection
of MO by first-pass perfusion has added prognostic value
over MO detected by EGE or LGE.
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